In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys | Zendy

Patrick Butaye | Zendy; Richard Ducatelle | Zendy; Julie De Backer | Zendy; Hans Vermeersch | Zendy; J.P. Remon | Zendy; Freddy Haesebrouck | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys

Author(s) -

Patrick Butaye,

Richard Ducatelle,

Julie De Backer,

Hans Vermeersch,

J.P. Remon,

Freddy Haesebrouck

Publication year - 1997

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.41.12.2800

Subject(s) - enrofloxacin , doxycycline , microbiology and biotechnology , antibiotics , chlamydia psittaci , chlamydia , biology , antibacterial agent , in vitro , ciprofloxacin , immunology , biochemistry

The in vitro susceptibility of 14 European Chlamydia psittaci strains from turkeys to the antibiotics doxycycline and enrofloxacin was tested. For doxycycline the MIC ranged from 0.05 to 0.2 microg/ml, with an average of 0.1 microg/ml. For enrofloxacin the MIC was 0.25 microg/ml. Acquired resistance was not detected against doxycycline and enrofloxacin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research